Document Detail

New Chemotherapeutic Strategies against Malaria, Leishmaniasis, and Trypanomiases.
MedLine Citation:
PMID:  23210775     Owner:  NLM     Status:  Publisher    
Due to the persistent lack of suitable vaccines, chemotherapy remains the only option for the treatment of patients infected by protozoan parasites. However, most available antiparasitic drugs have serious disadvantages, ranging from high cost and poor compliance to high toxicity and rapid induction of resistance. In recent decades basic research laboratories identified a considerable number of promising new molecules, but their development has not been pursued in depth by pharmaceutical firms because of poor prospects of economic return. The establishment of adequately funded public-private partnerships is currently reversing the trend. This review deals with new drugs against Plasmodium, Leishmania and Trypanosoma parasites, focusing on the molecules that are in the most advanced stage of development. The purpose of this article is to provide the reader with a panoramic view of the updated literature on the challenges and strategies of contemporary antiprotozoal drug research, paying the due attention to the already published reviews.
Mario Zucca; Sara Scutera; Dianella Savoia
Related Documents :
10084455 - Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
23024835 - Acs chemical neuroscience molecule spotlight on suvorexant.
23620145 - Rational use of generic psychotropic drugs.
23832265 - Medication adherence and knowledge of older patients with and without multidose drug di...
22927795 - Evolutionarily repurposed networks reveal the well-known antifungal drug thiabendazole ...
3107225 - Transdermal drug delivery and cutaneous metabolism.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-03
Journal Detail:
Title:  Current medicinal chemistry     Volume:  -     ISSN:  1875-533X     ISO Abbreviation:  Curr. Med. Chem.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9440157     Medline TA:  Curr Med Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Dept. of Clinical and Biological Sciences, at S. Luigi Gonzaga Hospital, University of Torino, Regione Gonzole 10, 10043 Orbassano (To), Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Kinase Ck2 inhibition: AN update.
Next Document:  New Molecular and Cellular Targets for Chemoprevention and Treatment of Skin Tumours by Plant Polyph...